All News Golden Biotechnology Corporation

Equities

4132

TW0004132006

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
27.15 ^TWD	-1.09%		-5.73%	-30.83%

Apr. 29	Golden Biotechnology Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 18	Golden Biotechnology Corp. Unveils the Findings of Its Phase II Clinical Trial Investigating Antroquinonol	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Golden Biotechnology Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29	CI
ASCO GI 2024, Golden Biotech's Antroquinonol Shows Significantly Prolonged Survival in Untreated Metastatic Pancreatic Cancer Patients	Jan. 19	AQ
Golden Biotechnology Corp. Unveils the Findings of Its Phase II Clinical Trial Investigating Antroquinonol	Jan. 18	CI
Golden Biotechnology Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-13	CI
Golden Biotech Announces Positive Results with Longer Survival Compared with Standard Treatments from Interim Analysis of Phase 2 Trial for Antroquinonol as 1st Line Treatment for Stage 4 Metastatic Pancreatic Cancer	23-05-05	CI
Golden Biotechnology Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Golden Biotechnology Corporation Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-11	CI
Golden Biotechnology Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-27	CI
Golden Biotechnology Corporation Announces Topline Results from Unblinded COVID-19 Trial for Oral New Drug Antroquinonol in Hospitalized Mild, Moderate and Severe Patients	22-01-07	CI
Golden Biotechnology Corporation Receives Antroquinonol Oral Covid-19 New Drug Trial Got Green Light from the FDA to Extend Recruiting Severe Covid-19 Patients	21-09-16	CI
Golden Biotechnology Corporation Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-15	CI
Golden Biotechnology Corporation Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-30	CI
GoldenBiotech's New Drug Antroquinonol Trial Receives Positive Response from DMC Review and Licenses for 4 Countries	21-02-04	CI
Golden Biotechnology Corp. Reports New Drug Trial of Antroquinonol -Outperforms Listing Drugs in Relapsed Acute Myeloid Leukemia	20-11-26	CI
Golden Biotechnology Corporation Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-11	CI
Anti-viral and Anti-Inflammatory Response: GoldenBiotech's Antroquinonol Receives FDA Approval on COVID-19 Phase 2 Trial in USA	20-07-01	AQ
Golden Biotechnology Corp. Announces it's Antroquinonol Receives FDA Approval on COVID-19 Phase 2 Trial in USA	20-07-01	CI
Golden Biotechnology Corporation Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-05	CI
Golden Biotechnology Corporation Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-06	CI
Golden Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2018	19-04-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Golden Biotechnology Corporation

Equities

4132

TW0004132006

All News

Filters